Formulation, characterization, and evaluation of doxorubicin-loaded cubosome as a cytotoxic potentiator against HCT-116 colorectal cancer cells
By: Almoshari, Yosif
.
Contributor(s): Mohammad Intakhab Alam.
Publisher: Karnataka Association of Pharmaceutical Teachers of India (APTI) 2022Edition: Vol.56(3), Jul-Sep.Description: 723-731p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical education and researchSummary: Background: Colorectal cancer (CRC) has grown to be the world’s fourth-biggest cause
of cancer-related mortality. It is critical to identify more effective treatment options for
it. Objectives: Doxorubicin a potent antineoplastic agent is widely used but has severe
adverse effects. Therefore, our objective is to use cubosome as an efficient drug delivery
system to reduce the off-target effects and increase the cytotoxic effects in CRC cells.
Materials and Methods: Pluronic F127-Based Cubosomes were prepared by low energy
stirring method and loaded with doxorubicin. Physicochemical characteristics were
studied using X-ray diffraction, dynamic light scattering, microscopic techniques, FTIR
UV spectrophotometer, and entrapment efficiency.
In vitro activity of doxorubicin-loaded
cubosomes was studied on HCT-116 cells. Results: The prepared cubosomes have the
required nano-size and the FTIR results showed the presence of both doxorubicin and
Pluronic F-127. The entrapment efficiency of doxorubicin was high too. DOX-CBs have
a better cytotoxic effect and induced ROS and reduced NO levels in HCT-116 cells.
Conclusion: The obtained results show that doxorubicin-loaded cubosomes can be used
to increase the cytotoxic effect in CRC cells and can be used with other chemotherapeutic
agents.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-1379 |
Background: Colorectal cancer (CRC) has grown to be the world’s fourth-biggest cause
of cancer-related mortality. It is critical to identify more effective treatment options for
it. Objectives: Doxorubicin a potent antineoplastic agent is widely used but has severe
adverse effects. Therefore, our objective is to use cubosome as an efficient drug delivery
system to reduce the off-target effects and increase the cytotoxic effects in CRC cells.
Materials and Methods: Pluronic F127-Based Cubosomes were prepared by low energy
stirring method and loaded with doxorubicin. Physicochemical characteristics were
studied using X-ray diffraction, dynamic light scattering, microscopic techniques, FTIR
UV spectrophotometer, and entrapment efficiency.
In vitro activity of doxorubicin-loaded
cubosomes was studied on HCT-116 cells. Results: The prepared cubosomes have the
required nano-size and the FTIR results showed the presence of both doxorubicin and
Pluronic F-127. The entrapment efficiency of doxorubicin was high too. DOX-CBs have
a better cytotoxic effect and induced ROS and reduced NO levels in HCT-116 cells.
Conclusion: The obtained results show that doxorubicin-loaded cubosomes can be used
to increase the cytotoxic effect in CRC cells and can be used with other chemotherapeutic
agents.
Click on an image to view it in the image viewer
There are no comments for this item.